Singh Remmi S, Wang Helen H
Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Mass., USA.
Acta Cytol. 2011;55(6):544-8. doi: 10.1159/000334214. Epub 2011 Dec 9.
The Bethesda System for reporting thyroid fine-needle aspirations (FNAs) recommends repeat aspirations be done at least 3 months following the initial aspiration to prevent false-positive misinterpretations due to reactive/reparative changes. Because limited data exists, we reviewed our own data to ascertain the recommendation.
We retrospectively reviewed thyroid FNAs accessioned in the Cytology Laboratory at Beth Israel Deaconess Medical Center in Boston, Mass., USA, from January 2006 to December 2008. We identified patients with repeat aspirates of a single lesion and those with thyroidectomy specimens. Cytologic and surgical diagnoses along with time between FNAs were recorded.
No statistically significant difference was detected in the distribution among nondiagnostic, suboptimal, and adequate categories with respect to the timing of repeat FNA (p = 0.25). Forty-six percent of the lesions that were nondiagnostic/suboptimal initially yielded the same results on repeat. Twenty-eight percent of initially adequate specimens were nondiagnostic/suboptimal on repeat (p = 0.04). Nine percent of those with an initial atypical diagnosis had the same diagnosis on repeat, while 2.6% of those who did not have an initial atypical diagnosis had an atypical diagnosis on repeat (p = 0.29). False positives between early (16%) and late (12%) repeats were not statistically significant (p = 0.74).
The diagnostic yield and accuracy of repeat FNA is independent of the time interval between procedures but may be related to the original FNA diagnosis.
甲状腺细针穿刺抽吸活检(FNA)报告的贝塞斯达系统建议,为防止因反应性/修复性改变导致假阳性误判,初次穿刺后至少3个月进行重复穿刺。由于现有数据有限,我们回顾了自身数据以确定该建议。
我们回顾性分析了2006年1月至2008年12月在美国马萨诸塞州波士顿贝斯以色列女执事医疗中心细胞实验室登记的甲状腺FNA病例。我们确定了对单个病变进行重复穿刺的患者以及有甲状腺切除标本的患者。记录了细胞学和手术诊断以及两次FNA之间的时间。
就重复FNA的时间而言,在非诊断性、次优和充分类别之间的分布未检测到统计学上的显著差异(p = 0.25)。最初非诊断性/次优的病变中有46%在重复穿刺时结果相同。最初充分的标本中有28%在重复穿刺时为非诊断性/次优(p = 0.04)。最初诊断为非典型的患者中有9%在重复穿刺时诊断相同,而最初未诊断为非典型的患者中有2.6%在重复穿刺时诊断为非典型(p = 0.29)。早期(16%)和晚期(12%)重复穿刺之间的假阳性无统计学显著差异(p = 0.74)。
重复FNA的诊断率和准确性与两次操作之间的时间间隔无关,但可能与最初的FNA诊断有关。